X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217659
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217782
https://www.financialexpress.com/healthcare/pharma-healthcare/usfda-gives-final-nod-to-zydus-tablets-for-treatment-of-seizures/3154959/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211747
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-28-2022-95999.pdf
https://www.prnewswire.com/news-releases/aucta-announced-fda-approval-of-a-generic-version-of-trileptaloxcarbazepine-oral-suspension-301694327.html#:~:text=PISCATAWAY%2C%20N.J.%2C%20Dec.,this%20product%20in%20early%202023.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215332
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209652
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215726
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215939
https://labblog.uofmhealth.org/body-work/common-anti-seizure-medication-associated-elevated-fracture-risk-kids-epilepsy
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212428
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212428
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-25-2019-1569469631.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206576
https://www.biospace.com/article/supernus-pharma-to-buy-biscayne-neurotherapeutics-in-potential-183-million-deal-am6a-/?s=79
http://www.pharmatimes.com/news/real_world_data_back_use_of_eisai,_bials_zebinix_in_epilepsy_1214415
https://globenewswire.com/news-release/2016/12/12/897034/0/en/Supernus-Wins-Appeal-Case-on-Oxtellar-XR.html
http://www.prnewswire.com/news-releases/ani-pharmaceuticals-announces-fda-approval-of-oxcarbazepine-tablets-300283377.html
http://www.fiercepharmaasia.com/story/japans-mhlw-slated-review-nippon-boehringer-high-blood-pressure-combo/2016-04-13
http://www.prnewswire.com/news-releases/viiv-healthcare-announces-phase-ii-study-results-for-first-two-drug-long-acting-injectable-regimen-for-hiv-1-treatment-569850931.html
http://ir.supernus.com/releasedetail.cfm?ReleaseID=892356
http://www.pharmabiz.com/NewsDetails.aspx?aid=86226&sid=2
Market Place
Share 
